- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 14, 2024
Companies with a Value score of at least 3, ordered by Value score
442 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AMPH | US$41.30 | -3.4% | -3.8% | US$2.1b | US$62.60 | PE13.1x | E16.8% | n/a | ||
EXAS | US$54.00 | -12.1% | -32.4% | US$10.3b | US$86.59 | PS3.9x | E65.9% | n/a | ||
KNSA | US$19.48 | -3.9% | 42.7% | US$1.4b | US$30.67 | PE159.8x | E44.1% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
OCUP | US$1.70 | -12.4% | -65.2% | US$43.0m | US$19.33 | PS2.3x | E51.0% | n/a | ||
INSM | US$25.45 | -2.4% | 38.5% | US$3.8b | US$44.63 | PS12x | E45.7% | n/a | ||
COLL | US$33.29 | -10.8% | 44.6% | US$1.1b | US$40.00 | PE11.7x | E15.1% | n/a | ||
CPHR.F | CA$6.39 | -5.3% | 146.7% | CA$212.7m | CA$7.84 | PE6.8x | E-14.6% | n/a | ||
SCYX | US$1.97 | 6.8% | -32.5% | US$77.1m | US$6.88 | PE0.7x | E-12.3% | n/a | ||
INDV | UK£17.53 | -1.0% | -7.3% | UK£1.9b | UK£30.43 | PE478.6x | E34.7% | 0% | ||
GILD | US$67.65 | 3.3% | -13.6% | US$84.1b | US$82.93 | PE173.8x | E36.5% | 4.6% | ||
PRGO | US$30.29 | 0.5% | -7.8% | US$4.2b | US$39.50 | PE5161.4x | E49.3% | 3.6% | ||
AMRX | US$6.85 | 5.2% | 237.4% | US$2.1b | US$8.25 | PE-12.5x | E118.9% | 0% | ||
PTGX | US$29.61 | 14.8% | 16.6% | US$1.7b | US$43.50 | PE10.7x | E0.8% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
PCRX | US$30.82 | 16.3% | -25.3% | US$1.4b | US$44.90 | PE20.4x | E29.9% | n/a | ||
VNDA | US$5.13 | -6.4% | -16.6% | US$293.9m | US$5.21 | PS1.7x | E30.9% | n/a | ||
OPTN | US$1.13 | 9.7% | -39.9% | US$169.5m | US$3.75 | PS2.3x | E59.9% | n/a | ||
LENZ | US$15.72 | -4.3% | n/a | US$406.3m | US$36.75 | PB2x | E46.6% | n/a | ||
BAYZ.F | €31.69 | 3.9% | -45.6% | €28.7b | €40.02 | PB0.9x | E48.6% | 0.4% | ||
EVO | €5.55 | 8.0% | -49.9% | €1.8b | €11.88 | PS2.3x | E59.3% | n/a | ||
GTHX | US$4.65 | 9.4% | 71.6% | US$241.5m | US$8.50 | PS2.9x | E48.3% | n/a | ||
CRLB.F | CA$2.02 | 1.0% | 32.0% | CA$1.2b | CA$4.30 | PB1.4x | E97.2% | n/a | ||
TCNN.F | CA$11.87 | 12.0% | 162.6% | CA$3.1b | CA$17.75 | PS1.9x | E133.5% | n/a |